tiprankstipranks
Surgery Partners Inc (SGRY)
NASDAQ:SGRY
US Market

Surgery Partners (SGRY) Earnings Dates, Call Summary & Reports

Compare
309 Followers

Earnings Data

Report Date
May 06, 2025
TBA Not Confirmed
Period Ending
2025 (Q1)
Consensus EPS Forecast
0.08
Last Year’s EPS
0.1
Same Quarter Last Year
Based on 10 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Mar 03, 2025
|
% Change Since: -0.54%
|
Next Earnings Date:May 06, 2025
Earnings Call Sentiment|Positive
Surgery Partners demonstrated robust financial performance in 2024 with record revenue and EBITDA growth, driven by strong organic growth and strategic acquisitions. The company successfully managed contractual rates and expanded its physician base, positioning itself well for 2025. However, higher transaction costs impacted cash flow, and potential legislative changes pose a manageable risk. Overall, the highlights significantly outweigh the lowlights, underscoring a positive outlook.
Company Guidance
During the call, Surgery Partners provided guidance for 2025, projecting net revenue between $3.3 billion and $3.45 billion and adjusted EBITDA ranging from $555 million to $565 million, reflecting double-digit growth and margin expansion in line with their long-term growth algorithm. The company reported 2024 net revenue growth of 13.5% and adjusted EBITDA growth of 16%, with margin expansion of 30 basis points. They performed over 656,000 surgical cases in 2024, an 8.4% increase from 2023, with significant contributions from acquisitions and organic growth, including a 50% rise in total joint procedures. The 2024 acquisition activity involved deploying nearly $400 million, adding seven surgical facilities, primarily in higher acuity specialties like orthopedics and spine. For 2025, $200 million is expected to be deployed in acquisitions, with $53 million already spent on three ASCs in California and Texas at an average purchase price multiple of approximately 8x. Surgery Partners also addressed legislative impacts, estimating that potential site neutrality policies would affect less than 1% of their net revenue, emphasizing that their facilities are well-positioned to benefit from any procedural shifts to lower-cost sites.
Record Revenue and EBITDA
Surgery Partners reported full-year adjusted EBITDA growth of 16% and net revenue growth of 13.5%, with the company surpassing $3 billion in revenue and $0.5 billion in adjusted EBITDA for the first time.
Strong Organic and Orthopedic Growth
Same facility revenue grew by 8%, with significant contributions from orthopedic procedures, including a 50% increase in total joint procedures.
Successful Acquisitions and De Novo Growth
The company added seven surgical facilities and opened eight de novo facilities in 2024. The pipeline for 2025 includes 12 facilities in development, supporting long-term growth.
Managed Care and Contractual Rate Confidence
Surgery Partners secured over 99% of expected contractual rates for 2025, with Medicare rate increases of approximately 3%, providing visibility into 2025 rate growth.
Strong Physician Recruitment
The company recruited over 750 new physicians in 2024, enhancing its focus on high-acuity specialties, particularly orthopedics.
---

Surgery Partners (SGRY) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

SGRY Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 06, 20252025 (Q1)
0.08 / -
0.1
Mar 03, 20252024 (Q4)
0.38 / 0.44
0.440.00% (0.00)
Nov 12, 20242024 (Q3)
0.25 / 0.19
0.190.00% (0.00)
Aug 06, 20242024 (Q2)
0.20 / 0.21
0.28-25.00% (-0.07)
May 07, 20242024 (Q1)
0.07 / 0.10
0.0825.00% (+0.02)
Feb 26, 20242023 (Q4)
0.38 / 0.44
0.2762.96% (+0.17)
Nov 07, 20232023 (Q3)
0.14 / 0.19
-0.021050.00% (+0.21)
Aug 01, 20232023 (Q2)
0.08 / 0.28
-0.031033.33% (+0.31)
May 01, 20232023 (Q1)
<0.01 / 0.08
-0.09188.89% (+0.17)
Mar 01, 20232022 (Q4)
0.20 / 0.27
0.2317.39% (+0.04)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

SGRY Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Mar 03, 2025$24.08$24.00-0.33%
Nov 12, 2024$31.43$29.57-5.92%
Aug 06, 2024$28.72$29.64+3.20%
May 07, 2024$25.60$27.77+8.48%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Surgery Partners Inc (SGRY) report earnings?
Surgery Partners Inc (SGRY) is schdueled to report earning on May 06, 2025, TBA Not Confirmed.
    What is Surgery Partners Inc (SGRY) earnings time?
    Surgery Partners Inc (SGRY) earnings time is at May 06, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is SGRY EPS forecast?
          SGRY EPS forecast for the fiscal quarter 2025 (Q1) is 0.08.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis